熱門資訊> 正文
EIGR、ADXN和BROG是上市前涨幅股之一
2024-04-04 21:20
- Eiger生物製藥(EIGR) 0
- ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS(ADXN) 0
- TWELVE SEAS INVESTMENT COMPANY(BROG) 0
- Gainers: Tevogen (TVGN) +95%.
- TC BioPharm (TCBP) +61% Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies.
- HWH International (HWH) +57%.
- Zhongchao (ZCMD) +27%.
- Allurion Technologies (ALUR) +27% Expands Virtual Care Suite to the United States
- Candel Therapeutics (CADL) +23% stock soars on positive data from mid-stage pancreatic cancer drug trial.
- Eiger BioPharmaceuticals (NASDAQ:EIGR) +17%.
- Addex Therapeutics (NASDAQ:ADXN) +15%.
- Levi Strauss (LEVI) +14%.
- Brooge Energy (NASDAQ:BROG) +12%.
More on premarket gainers & stock
- Addex stock climbs on launch of new company, Neurosterix
- Eiger reportedly files for Chapter 11, stock plunges 52%
- Historical earnings data for Addex Therapeutics
- Financial information for Addex Therapeutics
- Seeking Alpha’s Quant Rating on Brooge Energy
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
